Fidelity International’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.1M Buy
1,885,000
+70,000
+4% +$413K 0.01% 529
2025
Q1
$10.6M Buy
1,815,000
+20,000
+1% +$116K 0.01% 519
2024
Q4
$13.5M Buy
1,795,000
+260,000
+17% +$1.95M 0.01% 502
2024
Q3
$12.2M Buy
1,535,000
+30,000
+2% +$239K 0.01% 531
2024
Q2
$12.7M Buy
1,505,000
+154,365
+11% +$1.31M 0.01% 494
2024
Q1
$11.3M Buy
1,350,635
+150,000
+12% +$1.26M 0.01% 507
2023
Q4
$10.1M Hold
1,200,635
0.01% 504
2023
Q3
$12M Hold
1,200,635
0.01% 472
2023
Q2
$15.4M Buy
1,200,635
+13,010
+1% +$167K 0.02% 441
2023
Q1
$11M Sell
1,187,625
-38,050
-3% -$353K 0.01% 476
2022
Q4
$13.1M Buy
1,225,675
+120,290
+11% +$1.29M 0.02% 456
2022
Q3
$4.47M Buy
1,105,385
+15,000
+1% +$60.7K 0.01% 588
2022
Q2
$7.96M Buy
1,090,385
+25,010
+2% +$183K 0.01% 530
2022
Q1
$9.59M Buy
1,065,375
+40,000
+4% +$360K 0.01% 539
2021
Q4
$11.6M Buy
1,025,375
+25,000
+2% +$282K 0.01% 521
2021
Q3
$14.6M Buy
1,000,375
+125,030
+14% +$1.83M 0.02% 484
2021
Q2
$14.3M Buy
875,345
+50,010
+6% +$815K 0.02% 502
2021
Q1
$16.6M Sell
825,335
-200,025
-20% -$4.01M 0.02% 464
2020
Q4
$21.1M Sell
1,025,360
-100,010
-9% -$2.06M 0.03% 400
2020
Q3
$19.8M Buy
1,125,370
+229,950
+26% +$4.04M 0.02% 397
2020
Q2
$15.2M Buy
895,420
+29,995
+3% +$508K 0.02% 421
2020
Q1
$8.33M Sell
865,425
-110,200
-11% -$1.06M 0.01% 476
2019
Q4
$11.1M Buy
+975,625
New +$11.1M 0.02% 488